What Are the Challenges in Targeting the Intrinsic Pathway?
While targeting the intrinsic pathway holds promise, it also presents challenges. The redundancy and complexity of apoptotic signaling pathways often lead to resistance mechanisms. Moreover, therapeutic agents must selectively induce apoptosis in cancer cells while sparing normal cells. Understanding the molecular context and specific alterations in each cancer type is crucial for designing effective therapies.
